Citywide Infectious Diseases Conference (September 7, 2022)
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Citywide Infectious Diseases Conference will take place on Wednesday, September 7, 2022 at 12:00 P.M. Live attendance for this conference will be available in-person at Main Baylor Campus in room M.112, and virtually through Zoom.
Activity Information
Needs Statement
Infectious diseases faculty, fellows, residents, medical students, and pharmacists who are involved in the care of patients need to be regularly updated with the recent advances and guidelines in the field of infectious disease, including hospital-acquired infections, antimicrobial resistance, infections related to chemotherapy and immunomodulators, and travel-acquired infections. The conference aims to increase clinical knowledge of the learners in these topic areas, and to implement the advances and guidelines in clinical practice to enhance the quality of patient care and outcomes.
Educational Objectives
At the conclusion of the sessions, the participants should be able to:
- Identify and implement current clinical best practices for the diagnosis and treatment of hospital-acquired infections.
- Distinguish evidence-based strategies for diagnosing and treating COVID-19 and other viral respiratory infections.
- Recognize the various clinical manifestations of common opportunistic infections in patients with HIV/AIDS and in transplant recipients.
- Develop strategies to recognize and treat multidrug-resistant infections.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Other Health Professionals
Specialties
- Emergency Medicine
- Family and Community Medicine
- Internal Medicine
Interest Groups
- Hospital Medicine
- Primary Care
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenters
-
Cesar A. Arias, M.D., M.S., Ph.D.
Professor
McGovern Medical School
Houston, Texas
Disclosure:
Nothing to disclose.
-
Denisse Ramirez, M.D.
Infectious Disease Fellow
University of Texas Health Science Center at Houston
Disclosure:
Nothing to disclose.
Activity Director
-
Jose Serpa-Alvarez, M.D., M.S.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Cesar A. Arias, M.D., M.S., Ph.D.
Professor
McGovern Medical School
Houston, Texas
Disclosure:
- Research Support: Entasis Pharmaceuticals; MedMed Diagnostics; Merck & Co.
-
Robert Atmar, M.D.
John S. Dunn Research Foundation Clinical Professorship in Infectious Diseases Honoring Temple W. Williams, Jr., M.D.
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Megan Duffey, M.D.
Infectious Diseases Fellow
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Charles Ericsson, M.D.
Professor
University of Texas Health Science Center at Houston
Disclosure:
Nothing to disclose.
-
Daniel Musher, M.D.
Distinguished Service Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Jose Serpa-Alvarez, M.D., M.S.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenters: